{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:02:13Z","timestamp":1777579333557,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd004293.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000}}],"reference-count":169,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004293.pub3","type":"journal-article","created":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T04:07:05Z","timestamp":1413432425000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome"],"prefix":"10.1002","author":[{"given":"Yizhi","family":"Chen","sequence":"first","affiliation":[{"name":"Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases; Department of Nephrology; Beijing China 100853"},{"name":"Mario Negri Institute for Pharmacological Research; Department of Renal Medicine, Laboratory of Biostatistics, Clinical Research Center for Rare Diseases \"Aldo e Cele Dacc\u00f2\"; Ranica (Bergamo) Italy 24020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo","family":"Schieppati","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliera \"Ospedali Riuniti di Bergamo\"; Unit of Nephrology; Mario Negri Institute for Pharmacological Research Via Gavazzeni, 11 Bergamo Italy 24125"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[{"name":"Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases; Department of Nephrology; Beijing China 100853"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyan","family":"Cai","sequence":"additional","affiliation":[{"name":"Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases; Department of Nephrology; Beijing China 100853"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Zamora","sequence":"additional","affiliation":[{"name":"Ramon y Cajal Institute for Health Research (IRYCIS), CIBER Epidemiology and Public Health (CIBERESP) and Cochrane Collaborating Centre; Clinical Biostatistics Unit; Ctra. Colmenar km 9,100 Madrid Madrid Spain 28034"},{"name":"CIBER Epidemiologia y Salud Publica (CIBERESP); Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni A","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Mario Negri Institute for Pharmacological Research; Department of Renal Medicine, Laboratory of Biostatistics, Clinical Research Center for Rare Diseases \"Aldo e Cele Dacc\u00f2\"; Ranica (Bergamo) Italy 24020"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Braun","sequence":"additional","affiliation":[{"name":"MediClin M\u00fcritz-Klinikum Waren; Department of Internal Medicine; Weinbergstrasse 19 Waren\/M\u00fcritz Germany 17192"},{"name":"Mueritz-Klinik; Renal Services; Klink Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Perna","sequence":"additional","affiliation":[{"name":"Mario Negri Institute for Pharmacological Research; Department of Renal Medicine, Laboratory of Biostatistics, Clinical Research Center for Rare Diseases \"Aldo e Cele Dacc\u00f2\"; Ranica (Bergamo) Italy 24020"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0001|cit1","first-page":"51","article-title":"Methyl prednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy - a preliminary study","volume":"13","author":"Ahmed","year":"1994","journal-title":"Bangladesh Renal Journal"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0002|cit2","unstructured":"Rahman M Ahmed S Alam MR Selim SI Chowdhury MN Chowdhury SM Methyl prednisolone plus chlorambucil as compared with prednisolone alone for the treatment of idiopathic membranous nephropathy - a preliminary study [abstract] 10th Asian Colloquium in Nephrology; 1994, Dec 2-6; Karachi, Pakistan 1994 66"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub3-BIB0003|cit3","first-page":"571A","article-title":"A randomized study on treatment with adrenocorticotropic hormone in idiopathic membranous nephropathy [abstract no: F-PO1112]","volume":"17","author":"Arnadottir","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub3-BIB0004|cit4","first-page":"1327","article-title":"Randomized trial of pulse cyclophosphamide and prednisone vs. prednisone alone in idiopathic membranous nephropathy [abstract no: A0410]","volume":"7","author":"Austin","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Programs & Abst","key":"10.1002\/14651858.CD004293.pub3-BIB0005|cit5","first-page":"82A","article-title":"Cyclophosphamide is superior to chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency [abstract no: A0395]","volume":"8","author":"Branten","year":"1997","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/qjmed\/91.5.359","article-title":"Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency","volume":"91","author":"Branten","year":"1998","journal-title":"Qjm"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0007|cit7","unstructured":"Braun N Dietz K Vonthein R Erley C Risler T Remission and relapses in idiopathic membranous nephropathy. Description by a longitudinal multi-state Markov-model [abstract] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal 2004 34 5"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0008|cit8","first-page":"967","article-title":"Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 years follow-up of a prospective, randomized multi-centre study [abstract]","volume":"10","author":"Braun","year":"1995","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0009|cit9","first-page":"413","article-title":"Therapy of membranous glomerulonephritis with nephrotic syndrome. 5 years follow-up of a prospective, randomized multi-center study [abstract]","volume":"6","author":"Braun","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/oxfordjournals.qjmed.a068422","article-title":"The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party","volume":"74","author":"Cameron","year":"1990","journal-title":"Quarterly Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0011|cit11","first-page":"844","article-title":"The MRC trial of prednisolone in membranous nephropathy. The Working Party of the MRC Glomerulonephritis Registry [abstract]","volume":"3","author":"Cameron","year":"1988","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0012|cit12","first-page":"507","article-title":"The MRC trial of prednisolone in membranous nephropathy. The Working Party of the UK MRC Glomerulonephritis Registry [abstract]","volume":"3","author":"Cameron","year":"1988","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0013|cit13","first-page":"600","article-title":"Results of a controlled trial of alternate day prednisone (ADS) in idiopathic membranous glomerulonephritis (IMGN) [abstract]","volume":"27","author":"Cattran","year":"1985","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0014|cit14","first-page":"388","article-title":"Preliminary results of controlled trial of alternate-day prednisone in idiopathic membranous glomerulonephritis [abstract]","volume":"19","author":"Cattran","year":"1981","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0015|cit15","first-page":"208","article-title":"Results of a controlled trial of alternate day prednisone (P) in membranous nephropathy (IMGN) [abstract]","volume":"35","author":"Cattran","year":"1989","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1056\/NEJM198901263200403","article-title":"A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy","volume":"320","author":"Cattran","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub3-BIB0017|cit17","first-page":"271","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy [abstract]","volume":"4","author":"Cattran","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0019|cit18","unstructured":"Cattran DC Cyclosporine in the treatment of membranous nephropathy (MGN) [abstract] 12th International Congress of Nephrology; 1993, Jun 13-18; Jerusalem, Israel 1993 535"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0018|cit19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/ki.1995.161","article-title":"A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group","volume":"47","author":"Cattran","year":"1995","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney International"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub3-BIB0021|cit21","first-page":"85A","article-title":"Randomized controlled trial of cyclosporine (D) vs placebo (P) in steroid resistant, nephrotic patients (NS) with membranous nephropathy (SR-MGN) [abstract]","volume":"9","author":"Cattran","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0022|cit22","first-page":"7","article-title":"Clinical correlates of serial urinary membrane attack complex estimates in patients with idiopathic membranous nephropathy","volume":"60","author":"Cattran","year":"2003","journal-title":"Clinical Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1440-1797.2007.00822.x","article-title":"Prospective controlled study on mycophenolate mofetil and prednisolone in the treatment of membranous nephropathy with nephrotic syndrome","volume":"12","author":"Chan","year":"2007","journal-title":"Nephrology"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub3-BIB0024|cit24","first-page":"802A","article-title":"A randomized controlled study comparing prednisone plus tacrolimus versus prednisone plus cyclophosphamide in patients with membranous nephropathy and nephrotic syndrome [abstract no: SA-PO1086]","volume":"17","author":"Chen","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MAJ.0b013e3181ca3a7d","article-title":"Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial","volume":"339","author":"Chen","year":"2010","journal-title":"American Journal of the Medical Sciences"},{"issue":"24","key":"10.1002\/14651858.CD004293.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM197912133012401","article-title":"A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome","volume":"301","author":"Coggins","year":"1979","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0027|cit27","first-page":"463","article-title":"The effect of short-term prednisone treatment in adult nephrotics with minimal change (MC) and membranous (M) histology [abstract]","volume":"12","author":"Coggins","year":"1977","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0028|cit28","first-page":"237","article-title":"A randomised and controlled study to assess the effect of cyclosporin in nephrotic patients with membranous nephropathy and reduced renal function (CYCLOMEN)","volume":"7","author":"Laurens","year":"1994","journal-title":"Journal of Nephrology"},{"issue":"Sept","key":"10.1002\/14651858.CD004293.pub3-BIB0029|cit29","first-page":"95A","article-title":"Cyclosporine versus conservative therapy in patients with idiopathic membranous nephropathy (IMN) and deteriorating renal function: Results of the CYCLOMEN trial [abstract]","volume":"11","author":"Pisoni","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ki.1974.129","article-title":"Controlled trial of cyclophosphamide in idiopathic membranous nephropathy","volume":"6","author":"Donadio","year":"1974","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1053\/j.ajkd.2008.04.013","article-title":"Mycophenolate mofetil monotherapy in membranous nephropathy: a 1-year randomized controlled trial","volume":"52","author":"Dussol","year":"2008","journal-title":"American Journal of Kidney Diseases"},{"issue":"Abstracts","key":"10.1002\/14651858.CD004293.pub3-BIB0032|cit32","first-page":"566A","article-title":"Mycophenolate mofetil (MMF) in patients with idiopathic membranous nephropathy with nephrotic syndrome: a multicenter randomized trial [abstract no: TH-F-DS1092]","volume":"17","author":"Dussol","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0033|cit33","first-page":"A64","article-title":"Results of long-term randomised study of immunosuppressive treatment of patients with idiopathic membranous glomerulonephritis [abstract]","volume":"16","author":"Dyadyk","year":"2001","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-116-6-438","article-title":"Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network","volume":"116","author":"Falk","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"Oct","key":"10.1002\/14651858.CD004293.pub3-BIB0035|cit35","first-page":"341A","article-title":"Early versus late start of immunosuppressive therapy in patients with membranous nephropathy; a randomized study. [abstract no: SA-PO188]","volume":"15","author":"Branten","year":"2004","journal-title":"Journal of the American Society of Nephrology"},{"issue":"September, Prog","key":"10.1002\/14651858.CD004293.pub3-BIB0036|cit36","first-page":"668A","article-title":"Defining the optimal time of treatment start in patients with membranous nephropathy: a randomized study [abstract no: SU-PO969]","volume":"13","author":"Branten","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD004293.pub3-BIB0037|cit37","first-page":"60A","article-title":"No benefit of early start of immunosuppressive therapy in idiopathic membranous nephropathy [abstract no: F-FC264]","volume":"19","author":"Hofstra","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfp390","article-title":"Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial","volume":"25","author":"Hofstra","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0039|cit39","first-page":"571","article-title":"Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results","volume":"27","author":"Imbasciati","year":"1980","journal-title":"Minerva Nefrologica"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0045|cit40","unstructured":"Ponticelli C Treatment of membranous nephropathy (MN) [abstract] 9th Asian Colloquium in Nephrology; 1992, May 17-21; Seoul, Korea 1992 22 4"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0046|cit41","unstructured":"Ponticelli C Treatment of membranous nephropathy [abstract] 12th International Congress of Nephrology; 1993, Jun 13-18; Jerusalem, Israel 1993 565"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0040|cit42","first-page":"717","article-title":"Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy","volume":"19","author":"Ponticelli","year":"1983","journal-title":"Proceedings of the European Dialysis & Transplant Association"},{"issue":"15","key":"10.1002\/14651858.CD004293.pub3-BIB0041|cit43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM198404123101503","article-title":"Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"310","author":"Ponticelli","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0042|cit44","first-page":"554","article-title":"Controlled trial of monthly alternated courses of steroid and chlorambucil in idiopathic membranous nephropathy [abstract]","volume":"23","author":"Ponticelli","year":"1983","journal-title":"Kidney International"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0043|cit45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198901053200102","article-title":"A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy","volume":"320","author":"Ponticelli","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0044|cit46","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0047|cit47","first-page":"282","article-title":"Clinical and morphologic evolution of idiopathic membranous nephropathy","volume":"25","author":"Zucchelli","year":"1986","journal-title":"Clinical Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000167547","article-title":"Prognostic value of T lymphocyte subset ratio in idiopathic membranous nephropathy","volume":"8","author":"Zucchelli","year":"1988","journal-title":"American Journal of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.2007020166","article-title":"A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy","volume":"18","author":"Jha","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Suppl","key":"10.1002\/14651858.CD004293.pub3-BIB0050|cit50","first-page":"A16","article-title":"A randomized controlled trial of steroids and cyclophosphamide in adults with idiopathic membranous nephropathy [abstract no: FC3-02]","volume":"8","author":"Jha","year":"2003","journal-title":"Nephrology"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub3-BIB0051|cit51","first-page":"213A","article-title":"Randomized controlled trial of steroids and cyclophosphamide in adults with idiopathic membranous nephropathy [abstract]","volume":"12","author":"Jha","year":"2001","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0052|cit52","unstructured":"Jha V Saha TK Kohli HS Sud K Gupta KL Joshi K A randomized controlled trial of steroids and cyclophosphamide in adults with idiopathic membranous nephropathy [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998, Jun 6-9; Rimini, Italy 1998 114"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD004293.pub3-BIB0053|cit53","first-page":"FP347","article-title":"Efficacy and safety of triple therapy with MMF, cyclosporine and prednisolone versus cyclosporine and prednisolone in adult patients with idiopathic membranous nephropathy and persistent heavy proteinuria [abstract]","volume":"27","author":"Jurubita","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0054|cit54","first-page":"631","article-title":"Clinical evaluation of an immunosuppressive drug, mizoribine (HE-69) on steroid-resistant nephrotic syndrome. A multicenter double-blind comparison study with placebo","volume":"34","author":"Koshisawa","year":"1993","journal-title":"Jin ToTohseki [Kidney & Dialysis]"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3109\/08860221003728754","article-title":"Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy","volume":"32","author":"Kosmadakis","year":"2010","journal-title":"Renal Failure"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0056|cit56","first-page":"303","article-title":"Treatment of membranous nephropathy with Tripterygium wilfordii and steroid: a prospective randomized control trial","volume":"18","author":"Liu","year":"2009","journal-title":"Shenzangbing Yu Touxi Shenyizhi Zazhi [Chinese Journal of Nephrology Dialysis & Transplantation]"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0057|cit57","first-page":"229","article-title":"Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis","volume":"37","author":"Murphy","year":"1992","journal-title":"Clinical Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biopha.2010.10.009","article-title":"Cyclosporine versus azathioprine therapy in high-risk idiopathic membranous nephropathy patients: A 3-year prospective study","volume":"65","author":"Naumovic","year":"2011","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0059|cit59","first-page":"350","article-title":"Prognosis and management of membraneous nephropathy","volume":"41","author":"Pahari","year":"1993","journal-title":"Journal of the Association of Physicians of India"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0061|cit60","unstructured":"Ponticelli C Treatment of idiopathic membranous nephropathy (IMN) [abstract] Pakistan Society of Nephrology & Urology. 10th Asian Colloquium in Nephrology; 1994, Dec 2-6; Karachi, Pakistan 1994 38"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub3-BIB0060|cit61","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199208273270904","article-title":"Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group","volume":"327","author":"Ponticelli","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy","volume":"9","author":"Ponticelli","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","article-title":"A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy","volume":"47","author":"Ponticelli","year":"2006","journal-title":"American Journal of Kidney Diseases"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.ki.5002215","article-title":"Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial","volume":"71","author":"Praga","year":"2007","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-121-5-199409010-00003","article-title":"Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide","volume":"121","author":"Reichert","year":"1994","journal-title":"Annals of Internal Medicine"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub3-BIB0066|cit66","first-page":"285","article-title":"Chlorambucil but not pulse cyclophosphamide reverses the deterioration of renal function in patients with membranous glomerulonephropathy [abstract]","volume":"4","author":"Reichert","year":"1993","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0067|cit67","unstructured":"Saito T Watanabe M Ogahara S Shuto H Kataoka Y Significance of blood concentration of cyclosporine at 2 hours after administration for the treatment of idiopathic membranous nephropathy with steroid resistant nephrotic syndrome [abstract no: SA285] World Congress of Nephrology; 2009 May, 22-26; Milan, Italy 2009"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ndt\/gfm538","article-title":"Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study","volume":"23","author":"Senthil Nayagam","year":"2008","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10157-004-0276-0","article-title":"A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)","volume":"8","author":"Shibasaki","year":"2004","journal-title":"Clinical & Experimental Nephrology"},{"issue":"12","key":"10.1002\/14651858.CD004293.pub3-BIB0070|cit70","first-page":"1209","article-title":"Controlled trial of azathioprine in the nephrotic syndrome secondary to idiopathic membranous glomerulonephritis","volume":"115","author":"Western Canadian Glomerulonephritis Study Group","year":"1976","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0071|cit71","first-page":"606","article-title":"ACE inhibition versus corticosteroids in membranous nephropathy (ACIMEN)","volume-title":"European Union biomedical and health research: the BIOMED 1 programme","volume":"1","author":"Jong","year":"1995"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0072|cit72","first-page":"294","article-title":"ACE inhibition versus corticosteroids in membranous nephropathy (ACIMEN)","volume":"7","author":"Stegeman","year":"1994","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0073|cit73","unstructured":"Mathew TH The treatment of idiopathic glomerulonephritis Proceedings of the Second Asian Pacific Congress of Nephrology 1983 164 72"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0074|cit74","first-page":"603","article-title":"Australian glomerulonephritis trial: membranous glomerulonephritis, mesangiocapillary glomerulonephritis [abstract]","volume":"11","author":"Tiller","year":"1981","journal-title":"Australian & New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0075|cit75","first-page":"345","article-title":"A prospective randomised trial of cyclophosphamide, dipyridamole and warfarin in membranous and mesangiocapillary glomerulonephritis","volume-title":"Advances in Basic and Clinical Nephrology. 8th International Congress of Nephrology; 1981 June 7-12; Athens, Greece","author":"Tiller","year":"1981"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004293.pub3-BIB0076|cit76","first-page":"iii431","article-title":"A double-blinded prospective randomised study on the efficacy of corticosteroid plus cyclophosphamide or FK506 in idiopathic membranous nephropathy patients with nephrotic syndrome [abstract]","volume":"3","author":"Xu","year":"2010","journal-title":"NDT Plus"},{"issue":"Nov","key":"10.1002\/14651858.CD004293.pub3-BIB0077|cit77","first-page":"780A","article-title":"Induction and long-term treatment with Cyclosporin A in membranous glomerulonephritis with the nephrotic syndrome [abstract no: SA-PO1020]","volume":"16","author":"Alexopoulos","year":"2005","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1002\/14651858.CD004293.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/ndt\/gfl360","article-title":"Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome","volume":"21","author":"Alexopoulos","year":"2006","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1681\/ASN.V72290","article-title":"Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy","volume":"7","author":"Ambalavanan","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"Abstracts Issue","key":"10.1002\/14651858.CD004293.pub3-BIB0080|cit80","first-page":"561A","article-title":"Sirolimus therapy in idiopathic and lupus membranous nephropathy [abstract]","volume":"19","author":"Austin","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5270","key":"10.1002\/14651858.CD004293.pub3-BIB0081|cit81","first-page":"412","article-title":"Controlled trial of prednisone in adult patients with the nephrotic syndrome","volume":"3","author":"Black","year":"1970","journal-title":"British Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub3-BIB0082|cit82","first-page":"A155","article-title":"Immunosuppressive treatment in idiopathic membranous glomerulonephritis (MGN) with progressive renal function worsening [abstract]","volume":"14","author":"Dominguez-Gil","year":"1999","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Sept","key":"10.1002\/14651858.CD004293.pub3-BIB0083|cit83","first-page":"99A","article-title":"Immunosuppressive treatment in idiopathic membranous glomerulonephritis (MGN) with progressive renal function worsening [abstract]","volume":"11","author":"Torres","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1523-1755.2002.00124.x","article-title":"Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy","volume":"61","author":"Torres","year":"2002","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ndt\/gfh036","article-title":"Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate","volume":"19","author":"du Buf-Vereijken","year":"2004","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0087|cit86","first-page":"C8","article-title":"Unconjugated hyperbilirubinemia due to cyclosporin a (CyA) administration in children with nephrotic syndrome (NS) [abstract]","volume":"1","author":"Edefonti","year":"1987","journal-title":"Pediatric Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0086|cit87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000415387","article-title":"Unconjugated hyperbilirubinemia due to ciclosporin administration in children with nephrotic syndrome","volume":"67","author":"Edefonti","year":"1988","journal-title":"Contributions to Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0088|cit88","unstructured":"Edefonti A Ghio L Rizzoni G Rinaldi S Gusmano R Lama G Cyclosporine (CSA) vs cyclophosphamide (CYC) for children with frequently relapsing\/steroid dependant nephrotic syndrome (FR\/SDNS): long term study [abstract] 9th Congress. International Pediatric Nephrology Association; 1992 Aug 30 - Sept 4; Jerusalem, Israel 1992 C70"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0089|cit89","first-page":"310","article-title":"Cyclosporine (CSA) vs cyclophosphamide (CYC) for children with frequently relapsing\/steroid dependent nephrotic syndrome (FR\/SDNS): long term study [abstract]","volume":"3","author":"Edefonti","year":"1992","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0092|cit90","first-page":"147","article-title":"A multicenter controlled prospective trial with cyclosporine vs cyclophosphamide in frequent relapsers and steroid dependent patients with idiopathic nephrotic syndrome","volume":"2","author":"Ponticelli","year":"1989","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0093|cit91","unstructured":"Ponticelli C Ciclosporin in the treatment of idiopathic nephrotic syndrome [abstract] 10th Asian Colloquium in Nephrology; 1994, Dec 2-6; Karachi, Pakistan 1994 116"},{"issue":"12","key":"10.1002\/14651858.CD004293.pub3-BIB0090|cit92","first-page":"1326","article-title":"Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial","volume":"8","author":"Ponticelli","year":"1993","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004293.pub3-BIB0091|cit93","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000168206","article-title":"Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis. [Review] [39 refs]","volume":"10","author":"Ponticelli","year":"1990","journal-title":"American Journal of Nephrology"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000101367","article-title":"Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs","volume":"27","author":"Goumenos","year":"2007","journal-title":"American Journal of Nephrology"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub3-BIB0095|cit95","first-page":"655","article-title":"Treatment with chlorambucil and azathioprine in primary glomerulonephritis. Results of a \"controlled\" study","volume":"81","author":"Lagrue","year":"1975","journal-title":"Journal d Urologie et de Nephrologie"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0096|cit96","first-page":"584","article-title":"Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria","volume":"21","author":"Li","year":"2008","journal-title":"Journal of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0097|cit97","unstructured":"Majima K Hori Y Inoue T Ishizaki K Kinoshita E Nomura G The effects of treatment with prednisolone in patients with idiopathic membranous nephropathy [abstract] 11th International Congress of Nephrology; 1990, Jul 15-20; Tokyo, Japan 1990 117A"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0098|cit98","unstructured":"Michail S Filiopoulos V Kosmadakis G Tentolouris N Georgoulias C Gobou A Comparison of three regimens in patients with idiopathic membranous nephropathy (IMN) associated with nephrotic syndrome (NS) [abstract no: SP053] 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004, May 15-18; Lisbon, Portugal 2004 34"},{"issue":"5756","key":"10.1002\/14651858.CD004293.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.2.5756.239","article-title":"Controlled trial of azathioprine and prednisone in chronic renal disease. Report by Medical Research Council Working Party","volume":"2","author":"Anonymous","year":"1971","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0100|cit100","first-page":"163-5, 174","article-title":"Evaluation of efficacy of methylprednisolone, prednisolone and chlorambucil in idiopathic glomerulonephritis","volume":"95","author":"Nand","year":"1997","journal-title":"Journal of the Indian Medical Association"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0101|cit101","unstructured":"Plavljanic D Spoljar-Scukanec M Milutinovic S Tubular damage in patients with membranous nephropathy. The response to treatment [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998, Jun 6-9; Rimini, Italy 1998 193"},{"issue":"9","key":"10.1002\/14651858.CD004293.pub3-BIB0102|cit102","first-page":"A76","article-title":"Long-term follow-up of patients with stage II idiopathic membranous nephropathy (IMN)- good response to steroid and chlorambucil treatment [abstract]","volume":"12","author":"Polenakovic","year":"1997","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","article-title":"A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome","volume":"43","author":"Ponticelli","year":"1993","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0104|cit104","unstructured":"Rashid HU Khanam A Islam KM Treatment of membranous nephropathy with prednisolone and ACE-inhibitor [abstract] ISN XIII International Congress of Nephrology; 1995, Jul 2-6; Madrid, Spain 1995 269"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD004293.pub3-BIB0105|cit105","first-page":"615","article-title":"Ponticelli regime for membranous nephropathy - do Indians respond differently? [abstract]","volume":"18","author":"Gopal","year":"2003","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0106|cit106","first-page":"180","article-title":"Ponticelli regimen for membranous nephropathy - do Indians respond differently? [abstract]","volume":"12","author":"Sahay","year":"2002","journal-title":"Indian Journal of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0107|cit107","unstructured":"Shilov EM Krasnova TN Ivanov AA Ivanova LV Shnyakina OV Tareyeva IE Oral cyclophosphamide versus cyclophosphamide (CPA) pulses in membranous and mesangial GN [abstract] 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998, Jun 6-9; Rimini, Italy 1998 116"},{"issue":"7","key":"10.1002\/14651858.CD004293.pub3-BIB0108|cit108","first-page":"542","article-title":"The effect of tacrolimus combined with small dose of hormone on idiopathic membranous nephropathy","volume":"28","author":"Sun","year":"2008","journal-title":"Zhongguo Shiyong Neike Zazhi [Chinese Journal of Practical Internal Medicine]"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000186526","article-title":"A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children","volume":"59","author":"Tejani","year":"1991","journal-title":"Nephron"},{"issue":"12","key":"10.1002\/14651858.CD004293.pub3-BIB0110|cit110","first-page":"1305","article-title":"Cyclosporin A treatment for idiopathic membranous nephropathy","volume":"114","author":"Yao","year":"2001","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0111|cit111","unstructured":"Yao XD Li L Tang Z Hu WX Ying G Chen HP Prospective clinical trial of Cyclosporin A in idiopathic membranous nephropathy [abstract] 6th Asian Pacific Congress of Nephrology; 1995, Dec 5-9; Hong Kong 1995 52"},{"issue":"Program & Abstr","key":"10.1002\/14651858.CD004293.pub3-BIB0112|cit112","first-page":"668A","article-title":"Eculizumab (C5 complement inhibitor) in the treatment of idiopathic membranous nephropathy (IMN): preliminary baseline and pharmacokinetic (PK)\/pharmacodynamic (PD) data [abstract no: SU-PO970]","volume":"13","author":"Appel","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0113|cit113","unstructured":"Berg AL Treatment with adrenocorticotropic hormone in idiopathic membranous nephropathy http:\/\/www.controlled-trials.com 2007"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0114|cit114","unstructured":"Gaskin G A national, randomised controlled trial of immunosuppressive therapy in idiopathic membranous nephropathy with declining renal function. 2004 http:\/\/www.nihr.ac.uk\/Profile\/Pages\/NRRResults.aspx?publication_id=N0016094239"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0115|cit115","unstructured":"Hirayama K Koyama A CYPMEN (CYclosporine with\/without Prednisolone in MEmbranous Nephropathy) study. 2006 http:\/\/www.anzctr.org.au\/ACTRN12609000996268.aspx"},{"issue":"9868","key":"10.1002\/14651858.CD004293.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(12)61566-9","article-title":"Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial","volume":"381","author":"Howman","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0117|cit117","doi-asserted-by":"crossref","unstructured":"Mathieson PW The UK randomized controlled trial of Immunosuppression for progressive membranous nephropathy [abstract no: THOR048] Journal of the American Society of Nephrology 2011 11A","DOI":"10.1186\/ISRCTN99959692"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0118|cit118","unstructured":"Liu Z Tacrolimus treatment of patients with idiopathic membranous nephropathy http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00302523"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0119|cit119","unstructured":"Liu Z To compare the efficacy and safety of Tripterygium wilfordii (TW) versus valsartan in the membranous nephropathy (MN) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00518219"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0120|cit120","unstructured":"Saito T Combined therapy of prednisolone and mizoribine in membranous nephropathy with refractory nephrotic syndrome www.who.int\/trialsearch\/trial.aspx?trialid=JPRN-C000000368\u200e"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0121|cit121","unstructured":"ChiCTR-TRC-08000098 Research on integrated therapy of traditional Chinese medicine for membranous nephropathy http:\/\/www.chictr.org\/en\/proj\/show.aspx?proj=1290"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0122|cit122","unstructured":"ChiCTR-TRC-11001144 A prospective randomized study on the efficacy of steroid combined with CTX or tacrolimus in IMN patients with NS http:\/\/www.chictr.org\/en\/proj\/show.aspx?proj=261"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0123|cit123","unstructured":"CTRI\/2010\/091\/000231 Comparison of efficacy of tacrolimus versus cyclophosphamide in idiopathic membranous nephropathy http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=CTRI\/2010\/091\/000231"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0124|cit124","unstructured":"EUCTR2007-005410-39-ES Randomized pilot study comparing tacrolimus vs. cyclophosphamide-prednisone in idiopathic membranous nephropathy - MEMTAC http:\/\/apps.who.int\/trialsearch\/Trial.aspx?TrialID=EUCTR2007-005410-39-ES"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0125|cit125","unstructured":"JPRN-UMIN000001099 Optimal use of ciclosporin in membranous nephropathy (OCIM-NS study) http:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000001321&language=E"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0126|cit126","unstructured":"JPRN-UMIN000006939 High-dose gamma-globulin therapy for nephrotic membranous nephropathy patients http:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr\/ctr.cgi?function=brows&action=brows&type=summary&recptno=R000007975&language=E"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0127|cit127","unstructured":"NCT00805753 Dose-finding pilot study of ACTH in patients with idiopathic membranous nephropathy (MN) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00805753"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0128|cit128","unstructured":"NCT00843856 Mycophenylate mofetil and tacrolimus versus tacrolimus for the treatment of idiopathic membranous glomerulonephritis (IMG) (MTAC) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00843856"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0129|cit129","unstructured":"NCT01093157 A dose escalation study of long-acting ACTH gel in membranous nephropathy http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01093157"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0130|cit130","unstructured":"NCT01161459 Treatment of idiopathic membranous nephropathy with Tripterygium wilfordii plus steroid vs tacrolimus plus steroid http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01161459"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0131|cit131","unstructured":"NCT01180036 A randomized controlled trial of rituximab versus cyclosporine in the treatment of membranous nephropathy (IMN) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01180036"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0132|cit132","unstructured":"NCT01282073 Mycophenolate mofetil in patients with progressive idiopathic membranous nephropathy (MMFPRIMER) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01282073?"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0133|cit133","unstructured":"NCT01386554 Acthar for treatment of proteinuria in membranous nephropathy patients (CHART) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01386554?"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0134|cit134","unstructured":"NCT01508468 Evaluate rituximab treatment for idiopathic membranous nephropathy (GEMRITUX) http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01508468"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0272-6386(99)70081-8","article-title":"Does immunosuppression with prednisolone and azathioprine alter the progression of idiopathic membranous nephropathy?","volume":"34","author":"Ahuja","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD004293.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0138|cit138","doi-asserted-by":"publisher","first-page":"CD002948","DOI":"10.1002\/14651858.CD002948.pub2","article-title":"Herbal therapy for treating rheumatoid arthritis","volume":"2","author":"Cameron","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"19","key":"10.1002\/14651858.CD004293.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2169\/internalmedicine.49.3704","article-title":"Meta-analysis of tTripterygium wilfordii hook F in the immunosuppressive treatment of IgA nephropathy","volume":"49","author":"Chen","year":"2010","journal-title":"Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0140|cit140","first-page":"375","article-title":"Combination regimen of leflunomide plus methylprednisolone in a female patient with reactive arthritis and concomitant IgA nephropathy","volume":"123","author":"Chen","year":"2010","journal-title":"Chinese Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/ndt\/9.5.469","article-title":"Treatment of membranous nephropathy: a meta-analysis","volume":"9","author":"Couchoud","year":"1994","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2005.08.020","article-title":"Idiopathic membranous nephropathy: outline and rationale of a treatment strategy","volume":"46","author":"du Buf-Vereijken","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"229-40, W49-51","DOI":"10.7326\/0003-4819-151-4-200908180-00005","article-title":"Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial","volume":"151","author":"Goldbach-Mansky","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"20","key":"10.1002\/14651858.CD004293.pub3-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1536867X0900900202","article-title":"Updated tests for small-study effects in meta-analyses","volume":"9","author":"Harbord","year":"2009","journal-title":"The Stata Journal"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/MNH.0b013e32835026ed","article-title":"Membranous nephropathy: the start of a paradigm shift","volume":"21","author":"Herrmann","year":"2012","journal-title":"Current Opinion in Nephrology & Hypertension"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0147|cit147","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/ndt\/gfq017","article-title":"Alkylating agents in membranous nephropathy: efficacy proven beyond doubt","volume":"25","author":"Hofstra","year":"2010","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ndt\/gfr371","article-title":"Management of patients with membranous nephropathy","volume":"27","author":"Hofstra","year":"2012","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD004293.pub3-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy","volume":"25","author":"Hogan","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"issue":"8","key":"10.1002\/14651858.CD004293.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1681\/ASN.V581553","article-title":"Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials","volume":"5","author":"Imperiale","year":"1995","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0152|cit152","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/kisup.2012.20","article-title":"Idiopathic membranous nephropathy","volume":"2","author":"KDIGO","year":"2012","journal-title":"Kidney International - Supplement"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/ard.2003.008342","article-title":"Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis","volume":"63","author":"Lehman","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"13","key":"10.1002\/14651858.CD004293.pub3-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1517\/14656566.2010.494599","article-title":"Management of idiopathic membranous nephropathy","volume":"11","author":"Ponticelli","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"9337","key":"10.1002\/14651858.CD004293.pub3-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD004293.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ncpneph1007","article-title":"Rituximab for membranous nephropathy and immune disease: less might be enough","volume":"5","author":"Ruggenenti","year":"2009","journal-title":"Nature Clinical Practice Nephrology"},{"issue":"8777","key":"10.1002\/14651858.CD004293.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0140-6736(91)92143-P","article-title":"Levamisole in nephrotic syndrome","volume":"338","author":"Srivastava","year":"1991","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD004293.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/ard.2005.044248","article-title":"Safety and efficacy of leflunomide in the treatment of lupus nephritis refractory or intolerant to traditional immunosuppressive therapy: an open label trial","volume":"65","author":"Tam","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7","key":"10.1002\/14651858.CD004293.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/art.10411","article-title":"Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study","volume":"46","author":"Tao","year":"2002","journal-title":"Arthritis & Rheumatism"},{"issue":"8","key":"10.1002\/14651858.CD004293.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneph.2009.101","article-title":"Controversies in the treatment of idiopathic membranous nephropathy","volume":"5","author":"Waldman","year":"2009","journal-title":"Nature Reviews Nephrology"},{"issue":"10","key":"10.1002\/14651858.CD004293.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1681\/ASN.2012010058","article-title":"Treatment of idiopathic membranous nephropathy","volume":"23","author":"Waldman","year":"2012","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1002\/14651858.CD004293.pub3-BIB0164|cit164","first-page":"46","article-title":"Randomized trials published in some Chinese journals: how many are randomized?","volume":"10","author":"Wu","year":"2009","journal-title":"Trials [Electronic Resource]"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"c223","DOI":"10.1159\/000208990","article-title":"Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis","volume":"111","author":"Xu","year":"2009","journal-title":"Nephron Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD004293.pub3-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1523-1755.2000.00168.x","article-title":"A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome","volume":"58","author":"Yoshioka","year":"2000","journal-title":"Kidney International"},{"issue":"5","key":"10.1002\/14651858.CD004293.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2215\/CJN.07570712","article-title":"Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials","volume":"8","author":"Chen","year":"2013","journal-title":"Clinical Journal of The American Society of Nephrology: CJASN"},{"issue":"3","key":"10.1002\/14651858.CD004293.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0272-6386(04)00809-1","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review","volume":"44","author":"Perna","year":"2004","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD004293.pub3-BIB0169|cit169","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004293.pub2","article-title":"Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome","author":"Schieppati","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004293.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004293.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T21:19:03Z","timestamp":1650403143000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004293.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":169,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004293.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.721158847.793502091","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]}}}